Option chain shows key data for Sensei Biotherapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sensei Biotherapeutics.

Sensei Biotherapeutics (NASDAQ:SNSE) Stock, Option Chain

Sensei Biotherapeutics

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADXN

ATNI

BIVI

BOOM

ENSC

GNPX

ALPS ETF Trusthen & Steers Global Realty Majors ETF

INAB

IRTC

KSCP

MEDP

MKTW

NTBL

SNSE

TCBP

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Intraday Update

AKAN

AKTS

ASTI

ATGL

BIOR

BNED

BSFC

BTTR

CADL

DAVA

DECK

GNLX

GYRE

HLTH

IMCR

INTU

ISSC

KRON

LILM

LUCY

LUXH

MGNI

MRNO

MRUS

NCPL

NTES

OKLO

ONMD

PEGY

RDZN

ROST

SMFL

SMMT

SVMH

SWIN

TLSI

VSTM

WDAY

WORX

XCUR

ZCAR

Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Wall Street

Earnings

Eurozone

Commodities

Dow Surges 50 Points; US Durable Goods Orders Increase In April

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics Inc

Health Care

Press Releases

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference

Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Present at Upcoming Conferences

Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Participate in Citi's 2024 Global Healthcare Conference

General

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

AIM ImmunoTech

Aprea Therapeutics

BioCardia

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Channel Therapeutics Corporation Common Stock

Channel Therapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Evaxion Biotech A/S - American Depositary Share

Evaxion Biotech

Geovax Labs

Imunon

Immuron Limited - American Depositary Shares

Immuron

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

MetaVia

Mainz Biomed

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

Ocean Biomedical

Organovo Holdings

BiomX

PharmaCyte Biotech

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Senti Biosciences

Turnstone Biologics

HC Wainwright & Co.

Citigroup

Stephens & Co.

Oppenheimer

Piper Sandler

Comments

Sensei Biotherapeutics

Sensei Biotherapeutics (SNSE) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga